Immunotherapy Promising for Tx of Acute Myeloid Leukemia

Share this content:
Immunotherapy Promising for Tx of Acute Myeloid Leukemia
Immunotherapy Promising for Tx of Acute Myeloid Leukemia

THURSDAY, Sept. 22, 2016 (HealthDay News) -- A new type of immunotherapy involving natural killer (NK) cells may help treat acute myeloid leukemia (AML) patients, according to a study published in the Sept. 21 issue of Science Translational Medicine.

Todd Fehniger, M.D., Ph.D., associate professor of medicine at Washington University in St. Louis, and colleagues sought to enhance the inherent capabilities of NK cells. The researchers started with NK cells donated by patients' close relatives. Those cells were incubated overnight in a mixture of interleukins 12, 15, and 18.

Of nine AML patients who were given the therapy and could be followed, four had a complete remission for up to six months. A fifth had a partial remission. There were no major safety problems, according to Fehniger. Patients had only mild side effects, such as a slight fever.

The next step, Fehniger told HealthDay, is to test the NK therapy in a larger number of patients, at the highest dose used in this initial study. The researchers also plan to study NK cells in combination with other therapies, including "mini" bone marrow transplants.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Deaths, Cardiac Arrest Not Rare in Triathlon Participants

Deaths, Cardiac Arrest Not Rare in Triathlon Participants

Incidence of death or cardiac arrest 1.74 per 100,000 participants; higher incidence in men, with age

ACP Does Not Support Legalization of Assisted Suicide

ACP Does Not Support Legalization of Assisted Suicide

Legalization would affect trust in the patient-physician relationship, and in the medical profession

AAP: Epinephrine Admin Training Needed in Many Schools

AAP: Epinephrine Admin Training Needed in Many Schools

In 2015 to 2016, 2.7 percent reported that epinephrine was administered by unlicensed staff

is free, fast, and customized just for you!

Already a member?

Sign In Now »